The transfer drastically expands on the Biden administration’s motion final month to share about four million doses of the vaccine with Mexico and Canada. The AstraZeneca vaccine is extensively in use around the globe however not but licensed by the U.S. Food and Drug Administration.
The transfer comes because the White Home is more and more assured concerning the provide of the three vaccines being administered within the U.S., significantly following the restart of the single-dose Johnson & Johnson shot over the weekend.
“Given the sturdy portfolio of vaccines that the U.S. already has and which were licensed by the FDA, and provided that the AstraZeneca vaccine just isn’t licensed to be used within the U.S., we don’t want to make use of the AstraZeneca vaccine right here through the subsequent a number of months, mentioned White Home COVID-19 coordinator Jeff Zients. “Due to this fact the U.S. is choices to share the AstraZeneca doses with different international locations as they develop into out there.”